In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics

In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics

Donepezil is a reversible acetylcholinesterase inhibitor that is currently the most commonly prescribed drug for the treatment of Alzheimer’s disease. In general, donepezil is known as a safe and well-tolerated drug, and it was not associated with liver abnormalities in several clinical trials. Howe...

Full description

Bibliographic Details
Main Authors:	Sin-Eun Kim, Hyung-Ju Seo, Yeojin Jeong, Gyung-Min Lee, Seung-Bae Ji, So-Young Park, Zhexue Wu, Sangkyu Lee, Sunghwan Kim, Kwang-Hyeon Liu
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Pharmaceutics
Subjects:	donepezil metabolism metabolomics molecular networking multivariate analysis
Online Access:	https://www.mdpi.com/1999-4923/13/7/936

Similar Items

Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
by: Serge Gauthier
Published: (2020-12-01)

Suspected donepezil toxicity: A case report
by: Carmen Gust, et al.
Published: (2020-12-01)

Development of donepezil-induced hypokalemia following treatment of cognitive impairment
by: Dongryul Kim, et al.
Published: (2021-01-01)

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
by: Tariot Pierre, et al.
Published: (2012-06-01)

Effect of Water Extract of Mangosteen Pericarp on Donepezil Pharmacokinetics in Mice
by: Mingoo Bae, et al.
Published: (2021-08-01)

Delirium associated with donepezil in a patient with Alzheimer's disease: a case report.
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)

Delirium Associated with Donepezil in a Patient with Alzheimer’s Disease: a Case Report
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)

Effects of Concentration, Temperature and Polymer Type on Drug Release from Montmorillonite-Donepezil Nanocomposites
by: Naser Tavakoli, et al.
Published: (2013-04-01)

Gintonin facilitates brain delivery of donepezil, a therapeutic drug for Alzheimer disease, through lysophosphatidic acid 1/3 and vascular endothelial growth factor receptors
by: Sun-Hye Choi, et al.
Published: (2021-03-01)

Effects of Nano-Chitosan Loaded with Donepezil on Ethanol Induced Amnesia in Swiss-type Mice
by: Mahmood Heidari, et al.
Published: (2020-10-01)

Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy
by: Jin Lu, et al.
Published: (2020-06-01)

Donepezil Treatment for Alzheimer’s Disease in Chronic Dialysis Patients
by: Konstantina G. Yiannopoulou, et al.
Published: (2019-09-01)

Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A 11C-donepezil PET Study
by: Ikuko Mochida, et al.
Published: (2017-01-01)

Evaluation of donepezil and rivastigmine administration on the cognitive deficits induced by electroconvulsive therapy: A randomized, double-blind clinical trial
by: Masoumeh Nazarinasab, et al.
Published: (2019-11-01)

DONEPEZIL THERAPY OF UNDIFFERENTIATED DEMENTIA IN CLINICAL PRACTICE
by: Y. V. Zhitkova, et al.
Published: (2017-12-01)

Nontargeted Metabolomics by High-Resolution Mass Spectrometry to Study the In Vitro Metabolism of a Dual Inverse Agonist of Estrogen-Related Receptors β and γ, DN203368
by: Sin-Eun Kim, et al.
Published: (2021-05-01)

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial
by: Yun Jeong Hong, et al.
Published: (2019-05-01)

Effects of Donepezil Hydrochloride on Neuronal Response of Pyramidal Neuron of the CA1 Hippocampus in Rat Model of Alzheimer\'s Disease
by: Azade Eskandary, et al.
Published: (2019-03-01)

Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil
by: Al Asmari AK, et al.
Published: (2016-01-01)

TREATMENT OF RESISTANT DEPRESSIONS AND CASE OF SUCCESSFUL USE OF DONEPEZIL HCl IN THEIR THERAPY
by: Dragan Terzič
Published: (2001-07-01)

Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits
by: SHIGEKI SAKURABA, et al.
Published: (2009-01-01)

Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase
by: Tsuyoshi Sato, et al.
Published: (2015-09-01)

DW2009 Elevates the Efficacy of Donepezil against Cognitive Impairment in Mice
by: Dong-Yun Lee, et al.
Published: (2021-09-01)

PLGA Microspheres with Alginate-Coated Large Pores for the Formulation of an Injectable Depot of Donepezil Hydrochloride
by: Dohyun Kim, et al.
Published: (2020-04-01)

Effect of donepezil and memantine on improvement of cognitive function in patients with temporal lobe epilepsy
by: Marjan Oustad, et al.
Published: (2020-01-01)

Meta-analysis of efficacy and safety of Donepezil in treating cognitive decline of Parkinson's disease
by: Qiu-Ping Li, et al.
Published: (2021-08-01)

Evaluation of the Adverse Effects of Chronic Exposure to Donepezil (An Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments
by: Gilbert Audira, et al.
Published: (2020-09-01)

Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
by: Magdalena Markowicz-Piasecka, et al.
Published: (2018-01-01)

Synthesis of New Indole Derivatives Structurally Related to Donepezil and Their Biological Evaluation as Acetylcholinesterase Inhibitors
by: Samar I. Faggal, et al.
Published: (2012-04-01)

Inhibitory effect of donepezil on bradykinin-induced increase in the intracellular calcium concentration in cultured cortical astrocytes
by: Kouki Makitani, et al.
Published: (2017-05-01)

Diverse Effects of an Acetylcholinesterase Inhibitor, Donepezil, on Hippocampal Neuronal Death after Pilocarpine-Induced Seizure
by: Jeong Hyun Jeong, et al.
Published: (2017-11-01)

The Preventive Effect of Donepezil on Post-Operative Cognitive Disorder in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
by: Mojtaba Mansouri, et al.
Published: (2017-05-01)

Effects of donepezil on behavioural manifestations of thalamic infarction: a single case observation
by: Rodrigo eRiveros, et al.
Published: (2011-03-01)

Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil
by: Lupe Carolina Espinoza, et al.
Published: (2019-02-01)

Profiling donepezil template into multipotent hybrids with antioxidant properties
by: Eva Mezeiova, et al.
Published: (2018-01-01)

Postoperative Administration of the Acetylcholinesterase Inhibitor, Donepezil, Interferes with Bone Healing and Implant Osseointegration in A Rat Model
by: Faez Saleh Al-Hamed, et al.
Published: (2020-09-01)

Antagonism of morphine-induced central respiratory depression by donepezil in the anesthetized rabbit
by: MIKI TSUJITA, et al.
Published: (2007-01-01)

Effect of Donepezil and Hyoscyamoside on Improving Spatial Memory in Rats With Alzheimer\'s Disease
by: Fatemeh Heidari Soureshjani, et al.
Published: (2020-09-01)

Sustained release donepezil loaded PLGA microspheres for injection: Preparation, in vitro and in vivo study
by: Wenjia Guo, et al.
Published: (2015-10-01)

Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection
by: Xiaojun Tao, et al.
Published: (2021-08-01)